Laboratoires Euromedis Société anonyme (EPA:ALEMG)
France
· Delayed Price · Currency is EUR 4.220
+0.150 (3.69%)
Jun 20, 2025, 3:39 PM CET
EPA:ALEMG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 36.22 | 34.04 | 54.18 | 111.9 | 193.41 | Upgrade
|
| Other Revenue | 0.2 | 0.03 | 0 | - | -0.01 | Upgrade
|
| Revenue | 36.41 | 34.07 | 54.18 | 111.9 | 193.4 | Upgrade
|
| Revenue Growth (YoY) | 6.88% | -37.13% | -51.58% | -42.14% | 150.73% | Upgrade
|
| Cost of Revenue | 34.29 | 33.86 | 35.44 | 78.41 | 129.26 | Upgrade
|
| Gross Profit | 2.12 | 0.21 | 18.75 | 33.49 | 64.14 | Upgrade
|
| Selling, General & Admin | 3.1 | 4.21 | 25.35 | 27.23 | 28.03 | Upgrade
|
| Other Operating Expenses | -1.6 | 1.35 | -6.66 | -4.96 | -0.46 | Upgrade
|
| Operating Expenses | 1.72 | 5.77 | 23.88 | 29.3 | 34.17 | Upgrade
|
| Operating Income | 0.4 | -5.56 | -5.14 | 4.19 | 29.97 | Upgrade
|
| Interest Expense | -0.5 | -0.36 | -0.37 | -0.35 | -0.46 | Upgrade
|
| Interest & Investment Income | 0.62 | 27.78 | - | - | - | Upgrade
|
| Earnings From Equity Investments | - | - | 0.02 | 0.02 | -0.12 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.03 | -0.02 | -0.03 | -0.08 | 0.58 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.11 | -0.01 | 0.25 | 0.01 | -0.39 | Upgrade
|
| EBT Excluding Unusual Items | 0.43 | 21.83 | -5.27 | 3.79 | 29.58 | Upgrade
|
| Impairment of Goodwill | - | - | -0.09 | - | -0.72 | Upgrade
|
| Asset Writedown | -6 | 12.3 | -0.43 | -1.13 | -4.39 | Upgrade
|
| Other Unusual Items | -0.55 | -20.75 | -0.19 | -0.15 | 3.92 | Upgrade
|
| Pretax Income | -6.11 | 13.38 | -5.98 | 2.51 | 28.39 | Upgrade
|
| Income Tax Expense | -0 | 0.27 | -0.04 | 0.21 | 5.53 | Upgrade
|
| Earnings From Continuing Operations | -6.11 | 13.11 | -5.94 | 2.3 | 22.87 | Upgrade
|
| Minority Interest in Earnings | - | - | 0.01 | -0.05 | -0.2 | Upgrade
|
| Net Income | -6.11 | 13.11 | -5.93 | 2.26 | 22.66 | Upgrade
|
| Net Income to Common | -6.11 | 13.11 | -5.93 | 2.26 | 22.66 | Upgrade
|
| Net Income Growth | - | - | - | -90.05% | - | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | 0.21% | -4.50% | -15.98% | - | 19.87% | Upgrade
|
| EPS (Basic) | -2.12 | 4.56 | -1.97 | 0.75 | 7.53 | Upgrade
|
| EPS (Diluted) | -2.12 | 4.56 | -1.97 | 0.63 | 6.33 | Upgrade
|
| EPS Growth | - | - | - | -90.05% | - | Upgrade
|
| Free Cash Flow | - | - | -2.08 | 17.41 | 12.84 | Upgrade
|
| Free Cash Flow Per Share | - | - | -0.69 | 4.86 | 3.58 | Upgrade
|
| Gross Margin | 5.83% | 0.62% | 34.60% | 29.93% | 33.17% | Upgrade
|
| Operating Margin | 1.09% | -16.31% | -9.48% | 3.75% | 15.50% | Upgrade
|
| Profit Margin | -16.78% | 38.48% | -10.95% | 2.02% | 11.72% | Upgrade
|
| Free Cash Flow Margin | - | - | -3.84% | 15.56% | 6.64% | Upgrade
|
| EBITDA | 0.62 | -4.44 | -4.01 | 5.2 | 34.41 | Upgrade
|
| EBITDA Margin | 1.70% | -13.02% | -7.41% | 4.64% | 17.79% | Upgrade
|
| D&A For EBITDA | 0.22 | 1.12 | 1.12 | 1 | 4.44 | Upgrade
|
| EBIT | 0.4 | -5.56 | -5.14 | 4.19 | 29.97 | Upgrade
|
| EBIT Margin | 1.09% | -16.31% | -9.48% | 3.75% | 15.50% | Upgrade
|
| Effective Tax Rate | - | 2.01% | - | 8.35% | 19.46% | Upgrade
|
| Revenue as Reported | 40.28 | 37.43 | 61.35 | 117.61 | 195.62 | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.